Product Information
PHENELZINE SULFATE 15 MG TAB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.5862 per EA under NDC 59762011901. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762011901
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PHENELZINE SULFATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA011909FDA Approved
Before 1982
TE Code
AB
On Market Since
3/23/2011
Pharmacological Classes
Price Statistics
The NADAC for PHENELZINE SULFATE 15 MG TAB has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 3.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5862 per EA |
|---|---|
| All-time high | $0.6622 (Feb 10, 2016) |
| All-time low | $0.4765 (May 17, 2017) |
| 52-week high | $0.6054 |
| 52-week low | $0.5712 |
| Median price | $0.5675 |
| Average price | $0.5653 |
| Largest weekly change | +19.9% (Dec 18, 2019) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Phenelzine Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Monoamine Oxidase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PHENELZINE SULFATE 15 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for PHENELZINE SULFATE 15 MG TAB, manufactured by Mylan Pharmaceuticals Inc., is $0.5862 per EA (NDC 59762011901), effective Sep 30, 2026.
How has the price of PHENELZINE SULFATE 15 MG TAB changed over time?
Over the history we have for it, the NADAC for PHENELZINE SULFATE 15 MG TAB has declined 3.7%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PHENELZINE SULFATE 15 MG TAB?
Since Nov 28, 2013, the NADAC for PHENELZINE SULFATE 15 MG TAB has ranged from a low of $0.4765 (May 17, 2017) to a high of $0.6622 (Feb 10, 2016), with a median of $0.5675 per EA.
Are there cheaper alternatives to PHENELZINE SULFATE 15 MG TAB?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PHENELZINE SULFATE 15 MG TAB, is $0.5384 per EA — about 8% below PHENELZINE SULFATE 15 MG TAB.
Who manufactures PHENELZINE SULFATE 15 MG TAB?
PHENELZINE SULFATE 15 MG TAB (NDC 59762011901) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.